Shane Thomas Gleason

CIK: 0001966214

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)24 (92.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (7.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NSPR

InspireMD, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

NSPR
InspireMD, Inc.
May 19, 2026
Sale(S)
Direct
22.8K shares at avg. $1.01$23K
NSPR
InspireMD, Inc.
Feb 2, 2026
Sale(S)
Direct
2.9K shares at avg. $1.59$5K
NSPR
InspireMD, Inc.
Feb 2, 2026
Sale(S)
Direct
2K shares at avg. $1.60$3K
NSPR
InspireMD, Inc.
Jan 30, 2026
Sale(S)
Direct
2.9K shares at avg. $1.63$5K
NSPR
InspireMD, Inc.
Jan 29, 2026
Sale(S)
Direct
5K shares at avg. $1.65$8K
NSPR
InspireMD, Inc.
Jan 28, 2026
Sale(S)
Direct
12.4K shares at avg. $1.65$20K
NSPR
InspireMD, Inc.
Jan 27, 2026
Sale(S)
Direct
4.8K shares at avg. $1.66$8K
NSPR
InspireMD, Inc.
Jan 22, 2026
Sale(S)
Direct
8.4K shares at avg. $1.57$13K
NSPR
InspireMD, Inc.
Jan 21, 2026
Sale(S)
Direct
17.6K shares at avg. $1.62$29K
NSPR
InspireMD, Inc.
Jan 20, 2026
Sale(S)
Direct
3K shares at avg. $1.59$5K
NSPR
InspireMD, Inc.
Jan 16, 2026
Sale(S)
Direct
2.3K shares at avg. $1.61$4K
NSPR
InspireMD, Inc.
Jan 15, 2026
Sale(S)
Direct
2.9K shares at avg. $1.58$5K
NSPR
InspireMD, Inc.
Jan 14, 2026
Award(A)
Direct
453.4K shares-
NSPR
InspireMD, Inc.
May 30, 2025
Sale(S)
Direct
7.2K shares at avg. $2.51$18K
NSPR
InspireMD, Inc.
May 29, 2025
Sale(S)
Direct
3.8K shares at avg. $2.51$9K
NSPR
InspireMD, Inc.
May 27, 2025
Sale(S)
Direct
1.6K shares at avg. $2.51$4K
NSPR
InspireMD, Inc.
May 23, 2025
Sale(S)
Direct
2.5K shares at avg. $2.51$6K
NSPR
InspireMD, Inc.
Feb 25, 2025
Sale(S)
Direct
10K shares at avg. $3.65$37K
NSPR
InspireMD, Inc.
Feb 4, 2025
Sale(S)
Direct
5.1K shares at avg. $2.46$13K
NSPR
InspireMD, Inc.
Feb 3, 2025
Sale(S)
Direct
7.1K shares at avg. $2.51$18K
NSPR
InspireMD, Inc.
Jan 31, 2025
Sale(S)
Direct
9.9K shares at avg. $2.55$25K
NSPR
InspireMD, Inc.
Jan 30, 2025
Sale(S)
Direct
2.5K shares at avg. $2.51$6K
NSPR
InspireMD, Inc.
Jan 29, 2025
Sale(S)
Direct
3.7K shares at avg. $2.46$9K
NSPR
InspireMD, Inc.
Jan 28, 2025
Sale(S)
Direct
2.5K shares at avg. $2.61$6K
NSPR
InspireMD, Inc.
Jan 27, 2025
Sale(S)
Direct
3.9K shares at avg. $2.71$10K

		Type	Shares	Price		Ownership
May 19, 2026	NSPR InspireMD, Inc.	Sale(S)	22,778	$1.01	$23,006	Direct
Feb 2, 2026	NSPR InspireMD, Inc.	Sale(S)	2,941	$1.59	$4,676	Direct
Feb 2, 2026	NSPR InspireMD, Inc.	Sale(S)	2,000	$1.60	$3,208	Direct
Jan 30, 2026	NSPR InspireMD, Inc.	Sale(S)	2,900	$1.63	$4,730	Direct
Jan 29, 2026	NSPR InspireMD, Inc.	Sale(S)	5,000	$1.65	$8,250	Direct
Jan 28, 2026	NSPR InspireMD, Inc.	Sale(S)	12,395	$1.65	$20,464	Direct
Jan 27, 2026	NSPR InspireMD, Inc.	Sale(S)	4,781	$1.66	$7,956	Direct
Jan 22, 2026	NSPR InspireMD, Inc.	Sale(S)	8,411	$1.57	$13,239	Direct
Jan 21, 2026	NSPR InspireMD, Inc.	Sale(S)	17,593	$1.62	$28,553	Direct
Jan 20, 2026	NSPR InspireMD, Inc.	Sale(S)	2,955	$1.59	$4,710	Direct
Jan 16, 2026	NSPR InspireMD, Inc.	Sale(S)	2,250	$1.61	$3,627	Direct
Jan 15, 2026	NSPR InspireMD, Inc.	Sale(S)	2,909	$1.58	$4,593	Direct
Jan 14, 2026	NSPR InspireMD, Inc.	Award(A)	453,390	-	$0	Direct
May 30, 2025	NSPR InspireMD, Inc.	Sale(S)	7,186	$2.51	$18,037	Direct
May 29, 2025	NSPR InspireMD, Inc.	Sale(S)	3,760	$2.51	$9,438	Direct
May 27, 2025	NSPR InspireMD, Inc.	Sale(S)	1,572	$2.51	$3,946	Direct
May 23, 2025	NSPR InspireMD, Inc.	Sale(S)	2,482	$2.51	$6,230	Direct
Feb 25, 2025	NSPR InspireMD, Inc.	Sale(S)	10,000	$3.65	$36,500	Direct
Feb 4, 2025	NSPR InspireMD, Inc.	Sale(S)	5,132	$2.46	$12,625	Direct
Feb 3, 2025	NSPR InspireMD, Inc.	Sale(S)	7,073	$2.51	$17,753	Direct
Jan 31, 2025	NSPR InspireMD, Inc.	Sale(S)	9,923	$2.55	$25,304	Direct
Jan 30, 2025	NSPR InspireMD, Inc.	Sale(S)	2,454	$2.51	$6,160	Direct
Jan 29, 2025	NSPR InspireMD, Inc.	Sale(S)	3,660	$2.46	$9,004	Direct
Jan 28, 2025	NSPR InspireMD, Inc.	Sale(S)	2,476	$2.61	$6,462	Direct
Jan 27, 2025	NSPR InspireMD, Inc.	Sale(S)	3,858	$2.71	$10,455	Direct

1-25 of 26 transactions

About Gleason Shane Thomas

Gleason Shane Thomas (SEC CIK 0001966214) files insider reports with the SEC as Chief Commercial Officer of InspireMD, Inc. (NSPR).

Signal8 holds 4 ownership filings by Gleason Shane Thomas, all Form 4s, filed between Jan 10, 2025 and May 21, 2026. Those filings report 26 transactions, from Jan 7, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gleason Shane Thomas's filings is in MIAMI, FL.

Recent filings by Gleason Shane Thomas

May 19, 2026: Open-market sale of NSPR shares (Form 4, code S).
Feb 2, 2026: Open-market sales of NSPR shares (2 lines, Form 4, code S).
Jan 30, 2026: Open-market sale of NSPR shares (Form 4, code S).
Jan 29, 2026: Open-market sale of NSPR shares (Form 4, code S).
Jan 28, 2026: Open-market sale of NSPR shares (Form 4, code S).

Other insiders filing for InspireMD, Inc. (NSPR)

BERMAN MICHAEL, Director
ROUBIN GARY S, Director
Stuka Paul, Director
Slosman Marvin, CEO and President
Ward Scott R., Director
Tommasoli Andrea, Chief Operating Officer

How to read Form 4 transaction codes